DEKKERS MARIJN E 4
4 · Ginkgo Bioworks Holdings, Inc. · Filed Nov 7, 2022
Insider Transaction Report
Form 4
DEKKERS MARIJN E
Director
Transactions
- Sale
Class A Common Stock
2022-11-03$2.56/sh−171,455$438,925→ 2,021,132 total
Holdings
- 5,780,364(indirect: By Novalis LifeSciences Investments I, L.P.)
Class A Common Stock
Footnotes (2)
- [F1]Represents the number of shares sold by the Reporting Person pursuant to a 10b5-1 plan to cover such individual's estimated tax withholding obligations in connection with the vesting of restricted stock units.
- [F2]The reporting person is the manager of the general partner of Novalis LifeSciences Investments I, L.P. ("Novalis LifeSciences"), and as such, has sole voting and dispositive power over the shares held by Novalis LifeSciences and, as a result, may be deemed to share beneficial ownership of the shares held by Novalis LifeSciences.